Literature DB >> 26645206

Cue-induced striatal activity in frequent cannabis users independently predicts cannabis problem severity three years later.

W A M Vingerhoets1, L Koenders2, W van den Brink2, R W Wiers3, A E Goudriaan4, T van Amelsvoort5, L de Haan2, J Cousijn6.   

Abstract

Cannabis is the most frequently used illicit drug worldwide, but little is known about the mechanisms underlying continued cannabis use. Cue-reactivity (the physical, psychological, behavioural and neural reaction to substance-related cues) might be related to continued cannabis use. In this 3-year prospective neuroimaging study we investigated whether cannabis cue-induced brain activity predicted continued cannabis use and associated problem severity 3 years later. In addition, baseline brain activations were compared between dependent and non-dependent cannabis users at follow-up. Analyses were focussed on brain areas known to be important in cannabis cue-reactivity: anterior cingulate cortex, orbitofrontal cortex, ventral tegmental area, amygdala and striatum. At baseline, 31 treatment-naive frequent cannabis users performed a cue-reactivity functional magnetic resonance imaging task. Of these participants, 23 completed the 3-year follow-up. None of the cue-induced region of interest activations predicted the amount of cannabis use at follow-up. However, cue-induced activation in the left striatum (putamen) significantly and independently predicted problem severity at follow-up (p < 0.001) as assessed with the Cannabis Use Disorder Identification Test. Also, clinically dependent cannabis users at follow-up showed higher baseline activation at trend level in the left striatum compared with non-dependent users. This indicates that neural cue-reactivity in the dorsal striatum is an independent predictor of cannabis use-related problems. Given the relatively small sample size, these results are preliminary and should be replicated in larger samples of cannabis users.
© The Author(s) 2015.

Entities:  

Keywords:  Addiction; cannabis; cannabis use disorder; cue-reactivity; fMRI; striatum

Mesh:

Year:  2015        PMID: 26645206     DOI: 10.1177/0269881115620436

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

Review 1.  Drug-Induced Glucocorticoids and Memory for Substance Use.

Authors:  Elizabeth V Goldfarb; Rajita Sinha
Journal:  Trends Neurosci       Date:  2018-08-28       Impact factor: 13.837

2.  Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.

Authors:  Sarah D Lichenstein; Nick Manco; Lora M Cope; Leslie Egbo; Kathleen A Garrison; Jillian Hardee; Ansel T Hillmer; Kristen Reeder; Elisa F Stern; Patrick Worhunsky; Sarah W Yip
Journal:  Neuropsychopharmacology       Date:  2021-11-27       Impact factor: 8.294

3.  Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review.

Authors:  Kelly E Courtney; Margie Hernandez Mejia; Joanna Jacobus
Journal:  Curr Addict Rep       Date:  2017-05-06

4.  Approach bias modification for cannabis use disorder: A proof-of-principle study.

Authors:  Brian J Sherman; Nathaniel L Baker; Lindsay M Squeglia; Aimee L McRae-Clark
Journal:  J Subst Abuse Treat       Date:  2018-01-16

5.  Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies.

Authors:  M Taylor; J Cousijn; F Filbey
Journal:  Curr Addict Rep       Date:  2019-10-24

6.  The Neurobiology of Cannabis Use Disorders: A Call for Evidence.

Authors:  Valentina Lorenzetti; Janna Cousijn; Nadia Solowij; Hugh Garavan; Chao Suo; Murat Yücel; Antonio Verdejo-García
Journal:  Front Behav Neurosci       Date:  2016-05-10       Impact factor: 3.558

7.  Residual Effects of THC via Novel Measures of Brain Perfusion and Metabolism in a Large Group of Chronic Cannabis Users.

Authors:  Francesca M Filbey; Sina Aslan; Hanzhang Lu; Shin-Lei Peng
Journal:  Neuropsychopharmacology       Date:  2017-02-27       Impact factor: 7.853

8.  Heavy cannabis use, dependence and the brain: a clinical perspective.

Authors:  Emese Kroon; Lauren Kuhns; Eva Hoch; Janna Cousijn
Journal:  Addiction       Date:  2019-09-04       Impact factor: 6.526

9.  The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli.

Authors:  F M Filbey; D Beaton; S Prashad
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-11-20       Impact factor: 5.067

10.  FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder.

Authors:  Natalia M Kleinhans; Julia Sweigert; Matthew Blake; Bradley Douglass; Braden Doane; Fredrick Reitz; Mary Larimer
Journal:  Brain Behav       Date:  2020-08-30       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.